2 false false false false false false false false false false true false false false false false false No description of principal activity 2022-02-14 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 13914847 2022-02-14 2023-02-28 13914847 2023-02-28 13914847 2022-02-13 13914847 bus:Director2 2022-02-14 2023-02-28 13914847 core:WithinOneYear 2023-02-28 13914847 core:ShareCapital 2023-02-28 13914847 core:OtherReservesSubtotal 2023-02-28 13914847 core:RetainedEarningsAccumulatedLosses 2023-02-28 13914847 bus:SmallEntities 2022-02-14 2023-02-28 13914847 bus:AuditExemptWithAccountantsReport 2022-02-14 2023-02-28 13914847 bus:SmallCompaniesRegimeForAccounts 2022-02-14 2023-02-28 13914847 bus:PrivateLimitedCompanyLtd 2022-02-14 2023-02-28 13914847 bus:FullAccounts 2022-02-14 2023-02-28
COMPANY REGISTRATION NUMBER: 13914847
Cardo Health UK Limited
Filleted Unaudited Financial Statements
28 February 2023
Cardo Health UK Limited
Financial Statements
Period from 14 February 2022 to 28 February 2023
Contents
Page
Statement of financial position
1
Notes to the financial statements
2
Cardo Health UK Limited
Statement of Financial Position
28 February 2023
28 Feb 23
Note
£
Current assets
Cash at bank and in hand
60,637
Creditors: amounts falling due within one year
5
1,000
--------
Net current assets
59,637
--------
Total assets less current liabilities
59,637
--------
Net assets
59,637
--------
Capital and reserves
Called up share capital
100
Other reserves
850,000
Profit and loss account
( 790,463)
---------
Shareholders funds
59,637
---------
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
For the period ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 13 November 2023 , and are signed on behalf of the board by:
M Feigelman
Director
Company registration number: 13914847
Cardo Health UK Limited
Notes to the Financial Statements
Period from 14 February 2022 to 28 February 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 12 New Fetter Lane, London, EC4A 1JP, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The accounts have been prepared on a going concern basis which relies upon the continuing support of the investors.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Financial instruments
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses. Loans and borrowings are initially recognised at the transaction price including transaction costs. Subsequently, they are measured at amortised cost using the effective interest rate method, less impairment. If an arrangement constitutes a finance transaction it is measured at present value.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Employee numbers
The average number of persons employed by the company during the period amounted to 2 .
5. Creditors: amounts falling due within one year
28 Feb 23
£
Other creditors
1,000
-------
6. Controlling party
The ultimate parent company is Cardo Health AB , a company registered in Sweden. The registered address of the ultimate controlling party is: Nybrogatan 6 Stockholm, Stockholm County 114 34, SE .